Department of Immunology, Genetics and Pathology

For staff

The department’s information for staff is available in the staff gateway

For students

The department’s information for students is available in the student gateway

Research infrastructures

Seven research infrastructures in the form of service facilities are affiliated with the department

Rudbeck seminars

Here you can find the programme for the Rudbeck seminars

New research findings from IGP

  • Maintenance chemotherapy does not extend survival in CNS lymphoma

    Researchers at IGP have shown that maintenance chemotherapy with temozolomide does not result in an extended survival in patients with CNS lymphoma. The findings suggest that current treatment practice should be evaluated. Läs mer

  • Diabetes risk varies despite the same BMI

    Two people with the same body mass index or BMI may have entirely different risks of developing type 2 diabetes, depending on the biological mechanisms underlying their overweight. In a new study, IGP researchers describe the molecular processes that drive these differences. Läs mer

  • New biomarkers for detecting cancer

    Biomarkers in the blood could be used for the early detection of colorectal cancer, lung cancer and ovarian cancer. A new study from IGP shows that the performance of such biomarkers is comparable to or better than established tests and could be developed for clinical use. Läs mer

  • Different paediatric brain tumours originate from the same type of cell

    Researchers at IGP have discovered that severe brain tumours in children that appear to be completely different actually arise from the same type of cell. This cell type can give rise to tumours in the pineal gland, the retina and the cerebellum. The discovery that these tumours are related may make it possible to treat them in similar ways. Läs mer

  • Immunostimulatory gene therapy has been evaluated for patients with malignant melanoma

    A new clinical study shows promising results from treatment with immunostimulatory gene therapy in combination with checkpoint inhibitors for patients with malignant melanoma. The study has been published in the scientific journal Nature Communications. Läs mer

Show more

Last modified:

FOLLOW UPPSALA UNIVERSITY ON

Uppsala University on Facebook
Uppsala University on Instagram
Uppsala University on Youtube
Uppsala University on Linkedin